Teng Teng

5PUBLICATIONS
54CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2026
Suppressing phosphatidylserine externalization overcomes cancer immune evasion and enhances immunotherapy.

|Jun 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy.

|Apr 19, 2026
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers.

|Feb 20, 2018
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.

Michael Seiler, Akihide Yoshimi, Rachel Darman

|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.

Teng Teng, Jennifer Hc Tsai, Xiaoling Puyang

Pageof 1

Frequent Collaborators

3 joint publications

Jannik N Andersen

3 joint publications

Yi Yu

2 joint publications

Hongxiang Zhang

2 joint publications

Douglas A Whittington